Evidence map›Paper›PMID 38618720›Full record

ArticleCirculation research2024

Buffering Mechanism in Aortic Arch Artery Formation and Congenital Heart Disease.

AnnJosette Ramirez, Christina A Vyzas, Huaning Zhao, Kevin Eng, Karl Degenhardt, Sophie Astrof

Open access · greenAbstract read
In one paragraph

Article in Circulation research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Towards advanced regenerative therapeutics to tackle cardio-cerebrovascular diseases.American heart journal plus : cardiology research and practice · 2025
    Review
  4. Genetic and Environmental Contributors To Congenital Heart Disease.Current treatment options in cardiovascular medicine · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

AnnJosette RamirezDepartment of Cell Biology and Molecular Medicine (A.R., C.A.V., H.Z., S.A.), New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark.ORCID 0000-0002-0533-6473
Christina A VyzasDepartment of Cell Biology and Molecular Medicine (A.R., C.A.V., H.Z., S.A.), New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark.
Huaning ZhaoDepartment of Cell Biology and Molecular Medicine (A.R., C.A.V., H.Z., S.A.), New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark.ORCID 0000-0002-7931-4330
Kevin EngDepartment of Statistics, School of Arts and Sciences, Rutgers University, Piscataway, NJ (K.E.).
Karl DegenhardtChildren's Hospital of Pennsylvania, Department of Pediatrics, Division of Cardiology, University of Pennsylvania, Philadelphia (K.D.).ORCID 0009-0000-8613-0962
Sophie AstrofDepartment of Cell Biology and Molecular Medicine (A.R., C.A.V., H.Z., S.A.), New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark.ORCID 0000-0001-9338-9083
Rutgers, The State University of New Jersey · USChildren's Hospital of Philadelphia · US

Funding

Role of integrin a5 in the development of aortic arch arteries.R01HL103920 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ASTROF, SOPHIE · 2010 to 2024
$5.7M
Training in Tissue Engineering and Regenerative MedicineT32AR052273 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI SHAPIRO, IRVING M · 2006 to 2020
$3.3M
Role of fibronectin in the morphogenesis of the cardiac outflow tractR01HL134935 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI Sophie Astrof · 2017 to 2026
$2.2M
Identification of compensatory mechanisms to rescue aortic arch artery defectsR01HL158049 · NHLBI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI ASTROF, SOPHIE · 2022 to 2025
$1.9M
Investigating the requirement and regulation of vascular progenitors derived from the Second Heart Field in Pharyngeal Arch Artery developmentF31HL150949 · NHLBI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI RAMIREZ, ANNJOSETTE · 2020 to 2022
$121k
NHLBI NIH HHS F31 HL150949NHLBI NIH HHS R01 HL103920NHLBI NIH HHS R01 HL134935NHLBI NIH HHS R01 HL158049NIAMS NIH HHS T32 AR052273
6 · The paper itself

Abstract

backgroundThe resiliency of embryonic development to genetic and environmental perturbations has been long appreciated; however, little is known about the mechanisms underlying the robustness of developmental processes. Aberrations resulting in neonatal lethality are exemplified by congenital heart disease arising from defective morphogenesis of pharyngeal arch arteries (PAAs) and their derivatives.

methodsMouse genetics, lineage tracing, confocal microscopy, and quantitative image analyses were used to investigate mechanisms of PAA formation and repair.

resultsThe second heart field (SHF) gives rise to the PAA endothelium. Here, we show that the number of SHF-derived endothelial cells (ECs) is regulated by

conclusionsOur studies uncover a novel buffering mechanism underlying the resiliency of PAA development and remodeling.

Indexed as

Aorta, ThoracicEndothelial CellsHeart Defects, CongenitalT-Box Domain ProteinsVascular Endothelial Growth Factor Receptor-2AnimalsCell DifferentiationGene Expression Regulation, DevelopmentalMiceMice, Inbred C57BLKdr protein, mouseT-Box Domain ProteinsTbx1 protein, mouseVascular Endothelial Growth Factor Receptor-222q11 deletion syndromeaorta, thoracicductus arteriosusendothelial cellsveins

Identifiers

PMID38618720
PMCPMC11081845
OpenAlexW4394818683

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.